1.19

0.85% +0.01

Icecure Medical Ltd (ICCM)

Overview News Price History Discussions Forecast Stock Split

Icecure Medical Ltd stock is currently priced at $1.19, with a 24-hour trading volume of 77,740. It has seen a +0.85% increased in the last 24 hours and a -4.80% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $1.18 pivot point. If it approaches the $1.20 resistance level, significant changes may occur.

Previous Close:

$1.18

Open:

$1.2

24h Volume:

77,740

Market Cap:

$54.42M

Revenue:

$2.91M

Net Income/Loss:

$-15.61M

P/E Ratio:

-3.099

EPS:

-0.384

Net Cash Flow:

$-14.50M

1W Performance:

-0.83%

1M Performance:

-4.80%

6M Performance:

+56.56%

1Y Performance:

+1.71%

1D Range:

$1.174

$1.20

52W Range:

$0.52

$1.57

Icecure Medical Ltd Stock (ICCM) Company Profile

Name

Icecure Medical Ltd

Sector

Healthcare (1213)

Industry

Medical Devices (160)

Phone

972 4 623 0333

Address

7 Ha’Eshel Street, PO Box 3163, Caesarea

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ICCM's Discussions on Twitter

Icecure Medical Ltd Stock (ICCM) Latest News

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

IceCure Medical Ltd. (ICCM) Reports Q3 Loss, Misses Revenue Estimates

Zacks Investment Research

Icecure Medical Ltd Stock (ICCM) Financials Data

Icecure Medical Ltd (ICCM) Revenue 2024

ICCM reported a revenue (TTM) of $2.91 million for the quarter ending September 30, 2023, a -17.48% decline year-over-year.

Icecure Medical Ltd (ICCM) Net Income 2024

ICCM net income (TTM) was -$15.61 million for the quarter ending September 30, 2023, a +3.56% increase year-over-year.

Icecure Medical Ltd (ICCM) Cash Flow 2024

ICCM recorded a free cash flow (TTM) of -$14.50 million for the quarter ending September 30, 2023, a +14.82% increase year-over-year.

Icecure Medical Ltd (ICCM) Earnings per Share 2024

ICCM earnings per share (TTM) was -$0.361 for the quarter ending September 30, 2023, a +20.66% growth year-over-year.

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.